Anti-melanotransferrin and apolipoprotein E on doxorubicin-loaded cationic solid lipid nanoparticles for pharmacotherapy of glioblastoma multiforme-Reference-Cited by-同舟云学术

Anti-melanotransferrin and apolipoprotein E on doxorubicin-loaded cationic solid lipid nanoparticles for pharmacotherapy of glioblastoma multiforme

Published:2017-08 Issue: Volume:77 Page:10-20
ISSN:1876-1070
Container-title:Journal of the Taiwan Institute of Chemical Engineers
language:en
Short-container-title:Journal of the Taiwan Institute of Chemical Engineers

Author:

Kuo Yung-Chih,Hsu Cheng-Chih

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference69 articles.

1. Current concepts and management of glioblastoma;Preusser;Ann Neurol,2011

2. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein;Maletinska;Cancer Res,2000

3. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas;Ohgaki;J Neuropathol Exp Neurol,2005

4. Targeted imaging and therapy of brain cancer using theranostic nanoparticles;Bhojani;Mol Pharm,2010

5. Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview;Fujimaki;J Child Neurol,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier;International Journal of Pharmaceutics;2024-09

2. Going Nano for Neuro: Nanoparticle-Based Treatment of Central Nervous System Diseases;Smart Nanomaterials Technology;2024

3. Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma;Current Pharmaceutical Design;2023-06

4. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials;Journal of Liposome Research;2023-05-05

5. Solid lipid nanoparticles based drug delivery for targeting brain tumors;Nanocarriers for Drug-Targeting Brain Tumors;2022